TY - BOOK PY - 2018 DA - 2018// TI - Draft toxicological profile for perfluoroalkyls PB - Agency for Toxic Substances and Disease Registry CY - Atlanta ID - ref1 ER - TY - JOUR AU - Fletcher, T. AU - Galloway, T. S. AU - Melzer, D. AU - Holcroft, P. AU - Cipelli, R. AU - Pilling, L. C. AU - Mondal, D. AU - Luster, M. AU - Harries, L. W. PY - 2013 DA - 2013// TI - Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans JO - Environ Int VL - 57-58 UR - https://doi.org/10.1016/j.envint.2013.03.008 DO - 10.1016/j.envint.2013.03.008 ID - Fletcher2013 ER - TY - JOUR AU - Wolf, C. J. AU - Schmid, J. E. AU - Lau, C. AU - Abbott, B. D. PY - 2012 DA - 2012// TI - Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARalpha) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds JO - Reprod Toxicol VL - 33 UR - https://doi.org/10.1016/j.reprotox.2011.09.009 DO - 10.1016/j.reprotox.2011.09.009 ID - Wolf2012 ER - TY - JOUR AU - Geiger, S. D. AU - Xiao, J. AU - Ducatman, A. AU - Frisbee, S. AU - Innes, K. AU - Shankar, A. PY - 2014 DA - 2014// TI - The association between PFOA, PFOS and serum lipid levels in adolescents JO - Chemosphere VL - 98 UR - https://doi.org/10.1016/j.chemosphere.2013.10.005 DO - 10.1016/j.chemosphere.2013.10.005 ID - Geiger2014 ER - TY - JOUR AU - Nelson, J. W. AU - Hatch, E. E. AU - Webster, T. F. PY - 2010 DA - 2010// TI - Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population JO - Environ Health Perspect VL - 118 UR - https://doi.org/10.1289/ehp.0901165 DO - 10.1289/ehp.0901165 ID - Nelson2010 ER - TY - JOUR AU - Steenland, K. AU - Tinker, S. AU - Frisbee, S. AU - Ducatman, A. AU - Vaccarino, V. PY - 2009 DA - 2009// TI - Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant JO - Am J Epidemiol VL - 170 UR - https://doi.org/10.1093/aje/kwp279 DO - 10.1093/aje/kwp279 ID - Steenland2009 ER - TY - JOUR AU - Frisbee, S. J. AU - Shankar, A. AU - Knox, S. S. AU - Steenland, K. AU - Savitz, D. A. AU - Fletcher, T. AU - Ducatman, A. M. PY - 2010 DA - 2010// TI - Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 health project JO - Arch Pediatr Adolesc Med VL - 164 UR - https://doi.org/10.1001/archpediatrics.2010.163 DO - 10.1001/archpediatrics.2010.163 ID - Frisbee2010 ER - TY - JOUR AU - Fitz-Simon, N. AU - Fletcher, T. AU - Luster, M. I. AU - Steenland, K. AU - Calafat, A. M. AU - Kato, K. AU - Armstrong, B. PY - 2013 DA - 2013// TI - Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid JO - Epidemiology VL - 24 UR - https://doi.org/10.1097/EDE.0b013e31829443ee DO - 10.1097/EDE.0b013e31829443ee ID - Fitz-Simon2013 ER - TY - JOUR AU - Winquist, A. AU - Steenland, K. PY - 2014 DA - 2014// TI - Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts JO - Environ Health Perspect VL - 122 UR - https://doi.org/10.1289/ehp.1307943 DO - 10.1289/ehp.1307943 ID - Winquist2014 ER - TY - JOUR AU - Fisher, M. AU - Arbuckle, T. E. AU - Wade, M. AU - Haines, D. A. PY - 2013 DA - 2013// TI - Do perfluoroalkyl substances affect metabolic function and plasma lipids?--Analysis of the 2007-2009, Canadian health measures survey (CHMS) cycle 1 JO - Environ Res VL - 121 UR - https://doi.org/10.1016/j.envres.2012.11.006 DO - 10.1016/j.envres.2012.11.006 ID - Fisher2013 ER - TY - JOUR AU - Donat-Vargas, C. AU - Bergdahl, I. A. AU - Tornevi, A. AU - Wennberg, M. AU - Sommar, J. AU - Koponen, J. AU - Kiviranta, H. AU - Akesson, A. PY - 2019 DA - 2019// TI - Associations between repeated measure of plasma perfluoroalkyl substances and cardiometabolic risk factors JO - Environ Int VL - 124 UR - https://doi.org/10.1016/j.envint.2019.01.007 DO - 10.1016/j.envint.2019.01.007 ID - Donat-Vargas2019 ER - TY - JOUR AU - Grandjean, P. PY - 2018 DA - 2018// TI - Health status of workers exposed to perfluorinated alkylate substances (letter) JO - J Occup Environ Med VL - 60 UR - https://doi.org/10.1097/JOM.0000000000001411 DO - 10.1097/JOM.0000000000001411 ID - Grandjean2018 ER - TY - BOOK AU - Feingold, K. R. AU - Grunfeld, C. PY - 2000 DA - 2000// TI - Introduction to lipids and lipoproteins ID - Feingold2000 ER - TY - JOUR AU - Krauss, R. M. PY - 2010 DA - 2010// TI - Lipoprotein subfractions and cardiovascular disease risk JO - Curr Opin Lipidol VL - 21 UR - https://doi.org/10.1097/MOL.0b013e32833b7756 DO - 10.1097/MOL.0b013e32833b7756 ID - Krauss2010 ER - TY - JOUR AU - Alaupovic, P. PY - 1996 DA - 1996// TI - Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins JO - Methods Enzymol VL - 263 UR - https://doi.org/10.1016/S0076-6879(96)63004-3 DO - 10.1016/S0076-6879(96)63004-3 ID - Alaupovic1996 ER - TY - STD TI - Jensen MK, Rimm EB, Furtado JD, Sacks FM. Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease. J Am Heart Assoc. 2012;1:jah3–e000232. ID - ref16 ER - TY - STD TI - Morton AM, Koch M, Mendivil CO, Furtado JD, Tjonneland A, Overvad K, Wang L, Jensen MK, Sacks FM. Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk. JCI Insight. 2018;3(4):e98045. ID - ref17 ER - TY - JOUR AU - Mendivil, C. O. AU - Rimm, E. B. AU - Furtado, J. AU - Chiuve, S. E. AU - Sacks, F. M. PY - 2011 DA - 2011// TI - Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease JO - Circulation VL - 124 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.056986 DO - 10.1161/CIRCULATIONAHA.111.056986 ID - Mendivil2011 ER - TY - JOUR AU - Kohan, A. B. PY - 2015 DA - 2015// TI - Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease JO - Curr Opin Endocrinol Diabetes Obes VL - 22 UR - https://doi.org/10.1097/MED.0000000000000136 DO - 10.1097/MED.0000000000000136 ID - Kohan2015 ER - TY - JOUR AU - Wyler von Ballmoos, M. C. AU - Haring, B. AU - Sacks, F. M. PY - 2015 DA - 2015// TI - The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis JO - J Clin Lipidol VL - 9 UR - https://doi.org/10.1016/j.jacl.2015.05.002 DO - 10.1016/j.jacl.2015.05.002 ID - Wyler von Ballmoos2015 ER - TY - JOUR AU - Sacks, F. M. AU - Bray, G. A. AU - Carey, V. J. AU - Smith, S. R. AU - Ryan, D. H. AU - Anton, S. D. AU - McManus, K. AU - Champagne, C. M. AU - Bishop, L. M. AU - Laranjo, N. PY - 2009 DA - 2009// TI - Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0804748 DO - 10.1056/NEJMoa0804748 ID - Sacks2009 ER - TY - JOUR AU - Haug, L. S. AU - Thomsen, C. AU - Becher, G. PY - 2009 DA - 2009// TI - A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring JO - J Chromatogr A VL - 1216 UR - https://doi.org/10.1016/j.chroma.2008.10.113 DO - 10.1016/j.chroma.2008.10.113 ID - Haug2009 ER - TY - JOUR AU - Calafat, A. M. AU - Wong, L. Y. AU - Kuklenyik, Z. AU - Reidy, J. A. AU - Needham, L. L. PY - 2007 DA - 2007// TI - Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and nutrition examination survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000 JO - Environ Health Perspect VL - 115 UR - https://doi.org/10.1289/ehp.10598 DO - 10.1289/ehp.10598 ID - Calafat2007 ER - TY - JOUR AU - Furtado, J. D. AU - Campos, H. AU - Appel, L. J. AU - Miller, E. R. AU - Laranjo, N. AU - Carey, V. J. AU - Sacks, F. M. PY - 2008 DA - 2008// TI - Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart trial JO - Am J Clin Nutr VL - 87 UR - https://doi.org/10.1093/ajcn/87.6.1623 DO - 10.1093/ajcn/87.6.1623 ID - Furtado2008 ER - TY - JOUR AU - Liu, G. AU - Dhana, K. AU - Furtado, J. D. AU - Rood, J. AU - Zong, G. AU - Liang, L. AU - Qi, L. AU - Bray, G. A. AU - DeJonge, L. AU - Coull, B. PY - 2018 DA - 2018// TI - Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: a prospective study JO - PLoS Med VL - 15 UR - https://doi.org/10.1371/journal.pmed.1002502 DO - 10.1371/journal.pmed.1002502 ID - Liu2018 ER - TY - JOUR AU - Baecke, J. A. AU - Burema, J. AU - Frijters, J. E. PY - 1982 DA - 1982// TI - A short questionnaire for the measurement of habitual physical activity in epidemiological studies JO - Am J Clin Nutr VL - 36 UR - https://doi.org/10.1093/ajcn/36.5.936 DO - 10.1093/ajcn/36.5.936 ID - Baecke1982 ER - TY - JOUR AU - Steenland, K. AU - Fletcher, T. AU - Savitz, D. A. PY - 2010 DA - 2010// TI - Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA) JO - Environ Health Perspect VL - 118 UR - https://doi.org/10.1289/ehp.0901827 DO - 10.1289/ehp.0901827 ID - Steenland2010 ER - TY - JOUR AU - Lin, C. Y. AU - Wen, L. L. AU - Lin, L. Y. AU - Wen, T. W. AU - Lien, G. W. AU - Chen, C. Y. AU - Hsu, S. H. AU - Chien, K. L. AU - Sung, F. C. AU - Chen, P. C. PY - 2011 DA - 2011// TI - Associations between levels of serum perfluorinated chemicals and adiponectin in a young hypertension cohort in Taiwan JO - Environ Sci Technol VL - 45 UR - https://doi.org/10.1021/es201964x DO - 10.1021/es201964x ID - Lin2011 ER - TY - JOUR AU - Sunderland, E. M. AU - Hu, X. C. AU - Dassuncao, C. AU - Tokranov, A. K. AU - Wagner, C. C. AU - Allen, J. G. PY - 2019 DA - 2019// TI - A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects JO - J Expo Sci Environ Epidemiol VL - 29 UR - https://doi.org/10.1038/s41370-018-0094-1 DO - 10.1038/s41370-018-0094-1 ID - Sunderland2019 ER - TY - JOUR AU - Zeng, X. W. AU - Qian, Z. AU - Emo, B. AU - Vaughn, M. AU - Bao, J. AU - Qin, X. D. AU - Zhu, Y. AU - Li, J. AU - Lee, Y. L. AU - Dong, G. H. PY - 2015 DA - 2015// TI - Association of polyfluoroalkyl chemical exposure with serum lipids in children JO - Sci Total Environ VL - 512-513 UR - https://doi.org/10.1016/j.scitotenv.2015.01.042 DO - 10.1016/j.scitotenv.2015.01.042 ID - Zeng2015 ER - TY - JOUR AU - Starling, A. P. AU - Engel, S. M. AU - Whitworth, K. W. AU - Richardson, D. B. AU - Stuebe, A. M. AU - Daniels, J. L. AU - Haug, L. S. AU - Eggesbo, M. AU - Becher, G. AU - Sabaredzovic, A. PY - 2014 DA - 2014// TI - Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian mother and child cohort study JO - Environ Int VL - 62 UR - https://doi.org/10.1016/j.envint.2013.10.004 DO - 10.1016/j.envint.2013.10.004 ID - Starling2014 ER - TY - JOUR AU - Chateau-Degat, M. L. AU - Pereg, D. AU - Dallaire, R. AU - Ayotte, P. AU - Dery, S. AU - Dewailly, E. PY - 2010 DA - 2010// TI - Effects of perfluorooctanesulfonate exposure on plasma lipid levels in the Inuit population of Nunavik (northern Quebec) JO - Environ Res VL - 110 UR - https://doi.org/10.1016/j.envres.2010.07.003 DO - 10.1016/j.envres.2010.07.003 ID - Chateau-Degat2010 ER - TY - JOUR AU - Sacks, F. M. AU - Alaupovic, P. AU - Moye, L. A. AU - Cole, T. G. AU - Sussex, B. AU - Stampfer, M. J. AU - Pfeffer, M. A. AU - Braunwald, E. PY - 2000 DA - 2000// TI - VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial JO - Circulation VL - 102 UR - https://doi.org/10.1161/01.CIR.102.16.1886 DO - 10.1161/01.CIR.102.16.1886 ID - Sacks2000 ER - TY - JOUR AU - Talayero, B. AU - Wang, L. AU - Furtado, J. AU - Carey, V. J. AU - Bray, G. A. AU - Sacks, F. M. PY - 2014 DA - 2014// TI - Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease JO - J Lipid Res VL - 55 UR - https://doi.org/10.1194/jlr.M042333 DO - 10.1194/jlr.M042333 ID - Talayero2014 ER - TY - JOUR AU - Huang, M. AU - Jiao, J. AU - Zhuang, P. AU - Chen, X. AU - Wang, J. AU - Zhang, Y. PY - 2018 DA - 2018// TI - Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population JO - Environ Int VL - 119 UR - https://doi.org/10.1016/j.envint.2018.05.051 DO - 10.1016/j.envint.2018.05.051 ID - Huang2018 ER - TY - JOUR AU - Scharmach, E. AU - Buhrke, T. AU - Lichtenstein, D. AU - Lampen, A. PY - 2012 DA - 2012// TI - Perfluorooctanoic acid affects the activity of the hepatocyte nuclear factor 4 alpha (HNF4alpha) JO - Toxicol Lett VL - 212 UR - https://doi.org/10.1016/j.toxlet.2012.05.007 DO - 10.1016/j.toxlet.2012.05.007 ID - Scharmach2012 ER - TY - JOUR AU - Hayhurst, G. P. AU - Lee, Y. H. AU - Lambert, G. AU - Ward, J. M. AU - Gonzalez, F. J. PY - 2001 DA - 2001// TI - Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis JO - Mol Cell Biol VL - 21 UR - https://doi.org/10.1128/MCB.21.4.1393-1403.2001 DO - 10.1128/MCB.21.4.1393-1403.2001 ID - Hayhurst2001 ER - TY - JOUR AU - Sanchez Garcia, D. AU - Sjodin, M. AU - Hellstrandh, M. AU - Norinder, U. AU - Nikiforova, V. AU - Lindberg, J. AU - Wincent, E. AU - Bergman, A. AU - Cotgreave, I. AU - Munic Kos, V. PY - 2018 DA - 2018// TI - Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs) - a comparison with lysosomotropic drugs JO - Chem Biol Interact VL - 281 UR - https://doi.org/10.1016/j.cbi.2017.12.021 DO - 10.1016/j.cbi.2017.12.021 ID - Sanchez Garcia2018 ER - TY - JOUR AU - Zhang, X. AU - Chen, L. AU - Fei, X. C. AU - Ma, Y. S. AU - Gao, H. W. PY - 2009 DA - 2009// TI - Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals JO - BMC Mol Biol VL - 10 UR - https://doi.org/10.1186/1471-2199-10-16 DO - 10.1186/1471-2199-10-16 ID - Zhang2009 ER -